BACKGROUND: Evaluating the adequacy of Medicare prescription drug program (Part D) and its low-income subsidy (LIS) requires a comprehensive understanding of drug spending in relation to household resources. OBJECTIVE: : To estimate out-of-pocket health care costs in the year before Part D, in context of total household spending, health status, and LIS eligibility. RESEARCH DESIGN: Nationally representative cross-sectional study. SUBJECTS: Two thousand two hundred thirty-one Medicare families in the 2005/2006 Health and Retirement Study. METHODS: We assessed health care costs as a share of household resources remaining after spending on essential housing, food, personal care, and transportation. Burdensome health care costs were defined as ...
Background: Since its inception, Medicare Part D requires beneficiaries to choose from a myriad of i...
The Medicare drug benefit (Medicare Part D ), provides federal subsidies to pay premiums and cost s...
"Out-of-pocket drug costs are rising at a rapid rate, including for insulin, a life-saving drug used...
This study developed a new measure of medication affordability that examines out-of-pocket drug expe...
University of Minnesota Ph.D. dissertation. May 2014. Major: Social and Administrative Pharmacy. Ad...
Issue: Fifty-six million people—17 percent of the U.S. population—rely on Medicare. Yet, its benefit...
Analyzes Medicare recipients' 2009 out-of-pocket healthcare expenses as a share of household spendin...
BackgroundThe association between the Medicare Part D low-income subsidy (LIS), gap coverage, and ou...
CONTEXT: Cost-related medication nonadherence (CRN) has been a persistent problem for individuals wh...
The original Medicare Part D benefit included a gap in coverage, commonly known as the “doughnut hol...
CONTEXT: The full effect of Medicare Part D, after the initial policy transition period and across t...
INTRODUCTION:To examine the relationship between chronic health conditions and out-of-pocket costs (...
OBJECTIVE: To assess whether gaining prescription drug coverage produces cost offsets in Medicare sp...
Health insurance plans with high deductibles increase exposure to health care costs, raising concern...
BACKGROUND: Disabled Americans who qualify for Medicare coverage typically have multiple chronic con...
Background: Since its inception, Medicare Part D requires beneficiaries to choose from a myriad of i...
The Medicare drug benefit (Medicare Part D ), provides federal subsidies to pay premiums and cost s...
"Out-of-pocket drug costs are rising at a rapid rate, including for insulin, a life-saving drug used...
This study developed a new measure of medication affordability that examines out-of-pocket drug expe...
University of Minnesota Ph.D. dissertation. May 2014. Major: Social and Administrative Pharmacy. Ad...
Issue: Fifty-six million people—17 percent of the U.S. population—rely on Medicare. Yet, its benefit...
Analyzes Medicare recipients' 2009 out-of-pocket healthcare expenses as a share of household spendin...
BackgroundThe association between the Medicare Part D low-income subsidy (LIS), gap coverage, and ou...
CONTEXT: Cost-related medication nonadherence (CRN) has been a persistent problem for individuals wh...
The original Medicare Part D benefit included a gap in coverage, commonly known as the “doughnut hol...
CONTEXT: The full effect of Medicare Part D, after the initial policy transition period and across t...
INTRODUCTION:To examine the relationship between chronic health conditions and out-of-pocket costs (...
OBJECTIVE: To assess whether gaining prescription drug coverage produces cost offsets in Medicare sp...
Health insurance plans with high deductibles increase exposure to health care costs, raising concern...
BACKGROUND: Disabled Americans who qualify for Medicare coverage typically have multiple chronic con...
Background: Since its inception, Medicare Part D requires beneficiaries to choose from a myriad of i...
The Medicare drug benefit (Medicare Part D ), provides federal subsidies to pay premiums and cost s...
"Out-of-pocket drug costs are rising at a rapid rate, including for insulin, a life-saving drug used...